Background and Objectives: Right ventricular longitudinal strain (RVLS) is a new parameter of RV function. We evaluated the relationship of RVLS by speckle-tracking echocardiography with functional and invasive parameters in pulmonary arterial hypertension (PAH) patients. Subjects and Methods: Thirty four patients with World Health Organization group 1 PAH (29 females, mean age 45±13 years old). RVLS were analyzed with velocity vector imaging. Results: Patients with advanced symptoms {New York Heart Association (NYHA) functional class III/IV} had impaired RVLS in global RV (RVLS global , -17±5 vs. -12±3%, p<0.01) and RV free wall (RVLS FW , -19±5 vs. -14±4%, p<0.01 to NYHA class I/II). Baseline RVLS global and RVLS FW showed significant correlation with 6-minute walking distance (r=-0.54 and r=-0.57, p<0.01 respectively) and logarithmic transformation of brain natriuretic peptide concentration (r=0.65 and r=0.65, p<0.01, respectively). These revealed significant correlations with cardiac index (r=-0.50 and r=-0.47, p<0.01, respectively) and pulmonary vascular resistance (PVR, r=0.45 and r=0.45, p=0.01, respectively). During a median follow-up of 33 months, 25 patients (74%) had follow-up examinations. Mean pulmonary arterial pressure (mPAP, 54±13 to 46±16 mmHg, p=0.03) and PVR (11±5 to 6±2 wood units, p<0.01) were significantly decreased with pulmonary vasodilator treatment. RVLS global (-12±5 to -16±5%, p<0.01) and RVLS FW (-14±5 to -18±5%, p<0.01) were significantly improved. The decrease of mPAP was significantly correlated with improvement of RVLS global (r=0.45, p<0.01) and RVLS FW (r=0.43, p<0.01). The PVR change demonstrated significant correlation with improvement of RVLS global (r=0.40, p<0.01). Conclusion: RVLS correlates with functional and invasive hemodynamic parameters in PAH patients. Decrease of mPAP and PVR as a result of treatment was associated with improvement of RVLS. (Korean Circ J 2015;45(5):398-407)
Introduction
Pulmonary arterial hypertension (PAH) is a progressive disease that can cause right ventricular (RV) dilatation and dysfunction as a result of increased pulmonary vascular resistance (PVR) and pulmonary arterial (PA) pressure. 1) 2) Echocardiographic evidence of RV systolic dysfunction and clinical features of right-sided heart failure have been regarded as the main determinants of morbidity and mortality in patients with PAH. [3] [4] [5] Despite the obvious clinical importance of assessing RV systolic function, the estimation of RV function can be challenging. 6 ,) 7) Because of their invasiveness and/or high-cost, right heart catheterization (RHC) and cardiac magnetic resonance imaging (CMR) are impractical for frequent serial assessment. Although transthoracic 2-dimensional echocardiography (2DE) provides important information about RV anatomy, function and hemodynamic status, the complex geometry of the RV makes accurate assessment by conventional 2DE difficult. 8) Moreover, conventional 2DE measures including velocity and displacement based analyses can be affected by translational motion of the heart and respiratory variation.
9)
Two-dimensional strain echocardiography has been introduced to assess regional and global RV function in various disease categories including PAH.
6)10-12) Because longitudinal shortening contributes to overall RV systolic function, RV longitudinal strain (RVLS) assessed by strain echocardiography can give direct information about regional and global RV mechanics. However, there are relatively small numbers of validation data in RV strain measurement. Thus, we compared RVLS with functional capacity and invasive hemodynamic data by RHC in patients with primary PAH.
Subjects and Methods

Study population
We retrospectively studied consecutive adult patients (>18 years of age) with World Health Organization (WHO) group 1 PAH evaluated from February 2000 to December 2007 in the PAH clinic of Cleveland Clinic. All patients fulfilled the contemporary diagnostic criteria, 13) and they had regular outpatient follow-ups in this institution. Patients with left ventricular (LV) systolic dysfunction, significant valvular heart disease, chronic thromboembolic disease, and pulmonary parenchymal diseases were excluded in this study. We included and analyzed echocardiographic data without change of medication during the time interval between echocardiography and RHC. Patients without baseline echocardiographic examination or RHC in this institution, with poor echocardiographic images unable to analyze, atrial fibrillation, or medication change during time interval of two examinations were excluded. This study protocol was approved by the Cleveland Clinic Institutional Review Board.
Echocardiography
Conventional 2DE examinations were performed according to the guidelines and standard recommendations of the American Society of Echocardiography and were recorded digitally. 14) In our institution, all echocardiographic images are stored digitally into echocardiographic database with digital imaging and communications in medicine standard format. Echocardiographic images were reviewed by sonographers unaware of the clinical, laboratory, and hemodynamic information. Conventional 2DE parameters were measured by an investigator. RV fractional area change (RVFAC) was calculated from the apical 4-chamber view using the percentage change in areas of the end-diastolic and endsystolic areas of the RV. The tricuspid annular plane systolic excursion (TAPSE) was recorded with M-mode echocardiography parallel to the lateral RV wall and across the tricuspid annular plane and measured as the distance of systolic movement of the RV annulus in the longitudinal direction. 8) RV Tei index was defined as the ratio of isovolumic relaxation time (IVRT) and isovolumic contraction time (IVCT) divided by ejection time (ET) of RV. 8) RV free wall thickness was measured using M mode from the subcostal view at the peak of the R wave at the level of the tricuspid valve chordae tendineae. RV Tei index was defined as the ratio of IVRT and IVCT divided by ET of RV. 8) PA systolic pressure was estimated from the maximal continuous-wave Doppler velocity of the tricuspid regurgitation (TR) jet imaged from multiple planes plus estimated central venous pressure calculated by the diameter of inferior vena cava and distensibility. 8) An average of three measurements was used for all analyses. RV strain and strain rate were analyzed off-line with Velocity Vector Imaging (VVI) software (Axius, Siemens Medical Solutions, Mountain View, CA, USA). After manual tracing of the endocardial border of the RV (about 10 to 16 points) over one frame, the endocardial borders were automatically tracked throughout the cardiac cycle. Myocardial velocity is derived as the ratio between frame-to-frame displacement of the speckles and the time interval. 12 Right-sided heart catheterization and other dataset RHC was performed using a 7-Fr balloon-tipped fluid filled catheter. Hemodynamic data included the PA systolic pressure (sPAP), mean PA pressure (mPAP), pulmonary capillary wedge pressure (PCWP), right atrium and RV pressures, and cardiac output.
Cardiac output was determined by the Fick method. PVR was calculated using the formula (mPAP-PCWP)/ cardiac output and reported in Wood units. A 6-minute walking distance was performed according to the American Thoracic Society protocol. 15) Total distance walked, expressed in meters, was recorded. Brain natriuretic peptide (BNP) was measured by Triage immunoassay reagents (Biosite, San Diego, CA, USA) formatted for Beckman Coulter instrumentation (Brea, CA, USA).
Reproducibility
Longitudinal strain measurements for each patient were performed offline in a blinded manner by two independent observers. Each observer performed two independent measurements of regional and global RV strain values with VVI on same echocardiographic images in a randomly selected 10 patients.
Statistical analyses
The data were analyzed using SPSS version 20.0 (SPSS Inc., Chicago, IL, USA) and MedCalc version 12.4 (MedCalc Software, Mariakerke, Belgium). Summary data are expressed as mean values±standard deviation or percentage of patients. Linear regression analysis was performed to evaluate the relationship between RVLS and other functional or invasive hemodynamic variables. Data were compared by independent samples t test or Mann-Whitney U test. A paired Student t test was applied to evaluate the difference of basal and follow-up values. In the variables without normal distribution, Wilcoxon signed rank test was used to evaluate the difference. To assess the overall differences on RVLS global between groups without versus with change of treatment (i.e. treatment initiation or intensification), applied a Linear Mixed Effects model with unstructured covariance for random effects was. Effects of groups were tested as a factor, time after initial echocardiographic assessment as a covariate, as well as time×group interactions. Variability was tested with 2-way analysis of variance with calculation of intra-and inter-observer standard error or measurement (SEM intra and SEM inter ). SEM intra expresses the random error by a single observe, while SEM inter is an indicator of the mean variation between different observers. 16) All tests were two-sided and p value<0.05 was considered statistically significant.
Results
Patient characteristics
A total 34 patients (29 females, mean age 45±13 years old) with WHO group I PAH {Dana Point group I: 26 idiopathic, 5 familial, and 3 associated with other diseases (2 with connective tissue disease and 1 with systemic to pulmonary shunt)} were included in this 3±7.1 vs. -13.4±4.4%, p=0.08, Fig. 1) . RVLS global showed good correlations with 6-minute walking distance (6MWD, r=-0.54, p<0.01) and logarithmic transformation of BNP concentration (Log BNP , r=0.65, p<0.01, Fig. 2A and C) . Also, RVLS FW demonstrated significant correlations with 6MWD (r=-0.57, p<0.01) and Log BNP (r=0.65, p<0.01, Fig. 2B and D) . RVLS global had significant correlations with hemodynamic parameters including mPAP (r=0.35, p<0.05), cardiac index (r=0.50, p<0.01, and PVR (r=-0.45, p=0.01, Fig. 3A , C, and E). RVLS FW showed similar correlation with cardiac index (r=-0.47, p<0.01) and PVR (r=0.45, p=0.01). However, it did not have a significant correlation with mPAP (r=0.31, p=0.08, Fig.  3B, D, and F) .
Follow-up echocardiography and right heart catheterization
Follow-up RHC data were available in 25 patients with median time interval of two RHCs was 33 months (inter-quartile range=21-57 months). During the period, they were treated with additional specific pulmonary vasodilator therapy ( Table 2 . With specific pulmonary vasodilator treatment, clinical symptoms were improved, 6MWDs were increased and BNP levels were decreased. RV systolic function was improved, and mPAP and PVR were decreased. RVLS global and RVLS FW were increased significantly. Follow-up RVLS global value also showed significant correlation with follow-up 6MWD (r=-0.44, p=0.04) whereas RVLS FW showed insignificant correlation (r=-0.40, p=0.06). As baseline log BNP , follow-up log BNP revealed significant correlations with RVLS global (r=0.75, p<0.01) and RVLS FW (r=0.68, p<0.01). There were significant correlations between the change of mPAP and RVLS global (r=0.45, p<0.01) and RVLS FW (r=0.43, p<0.01, Fig. 4A and B). The change of PVR also had significant correlations with change of RVLS global (r=0.40, p=0.01) and RVLS FW (r=0.31, p<0.05, Fig.  4C and D) .
No patient experienced deterioration of NYHA function class while on treatment. However, 5 patients had a worsening of 6MWD. In patients with worsening of 6MWD, RVLS global showed no significant change (from -13.5±3.8% to -13.9±4.7%, p=0.86). In patients with improvement of 6MWD, RVLS global improved from -12.7±5.8% to -16.0±5.2% (p=0.03). Interestingly, the RVFAC (a "conventional" marker of RV function) was significantly changed in both patient groups (in patients with worsening of 6MWD: from 20±4% to 26±4%, p=0.02; in patients with improvement in 6MWD: from 21±7% to 29±9%, p<0.01).
In our cohort, all patients underwent echocardiographic followup studies early (within 1 to 6 months, median 95 days) and late (>1 year, median 772 days). There were 6 patients without change of treatment after initial echocardiography and 28 patients with either treatment initiation or intensification (i.e., increase in dose or addition of another agent). Changes of RVLS global during follow-up are shown in Fig. 5 . There was an improvement of RVLS global during follow-up in patients with change of medication (p=0.03 for the difference in slopes). Interestingly, while RVLS global was overall higher in the group without the change of medication (p=0.04), there was no additional change during follow-up.
Variability
The SEM intra of RVLS global was 1.6% and SEM inter of RVLS global was 2.1%. The SEM intra of RVLS FW was 1.9% and SEM inter of RVLS FW was 2.6%. 
Discussion
Baseline RVLS correlated with functional capacity and hemodynamic parameters in PAH patients. RVLS changed in parallel with the changes of invasively measured mPAP and PVR. Furthermore, echocardiographic follow-up data showed that changes in RVLS reflect changes in treatment during follow-up. This is relevant since, to our knowledge, there are no studies documenting the changes in RVLS during pulmonary hypertension treatment. These findings imply that, while single measurement of RVLS is prognostically relevant, it may be also necessary to track changes in treatment to appreciate its impact, and improve prognostication. Finally, when compared to previous studies, 17) 18) in this manuscript we correlate RVLS with measured, rather than estimated, RVSP and pulmonary vascular resistance. This finding is also relevant since a recent study 19) showed that echocardiographic estimation may not be always accurate. Although RV systolic dysfunction is an important prognostic factor in PAH patients, RV assessment can be challenging. 20) RHC
gives important pressure-and flow-derived parameters in the diagnosis and management of PAH patients. 21) However, frequent serial measurement is invasive and impractical. 22) CMR is a useful imaging method providing morphological and functional information of the RV. Two-dimensional strain echocardiography is a new method providing relatively easy and angle-independent quantification of myocardial deformation on 2DE images. 12) Because the predominant orientation of muscle fiber in the RV is in the longitudinal plane, longitudinal motion of RV is a major determinant of RV systolic function, especially in patients with PAH. 
Limitations
In this retrospective and observational study, major limitations include the relatively small numbers of PAH patients and the number of PAH patients who did not have repeat right heart catheterization. Bias may have been introduced from patient selection. We were not able to assess if RVLS provided long-term prognostic information. However, the improvement in 6MWD was associated with the improvement of RVLS. This result suggests that the assessment of RVLS may be useful to track clinical changes in PAH patients. We analyzed RVLS with stored images, and the analysis may have been affected by image quality and echocardiographic machines. Secondly, we used a vendorindependent platform to measure RVLS with echocardiographic images studied by different echocardiographic machines. However, using a vendor-independent platform from different echocardiographic machines can be an option in the comparison of RVLS in serial echocardiographic examinations, especially in the assessment of treatment effects. Echocardiographic parameters and cardiac catheterization were not performed simultaneously. The decision for a second catheterization was made on clinical Data are presented at baseline, within the first 6 months, and after more than a year after initial echocardiogram. Patients were separated into the group already on treatment for pulmonary hypertension (n=6), and a group of in whom treatment was initiated or in intensified (n=28) after the baseline echocardiogram. Patients who were already on treatment had better RVLS global (p=0.04) during the study period. However, patients in whom treatment was initiated or intensified showed significant improvement in RVLS global during follow up (p=0.03). Error bars show 1 standard deviation. RVLS global : right ventricular global longitudinal strain of right ventricle.
grounds. There were no specific criteria for a second heart catheterization. Nonetheless, a prospective study with large numbers of patients using the same echocardiographic machine will be needed to confirm the correlations and the clinical impact of this measurement.
Conclusions
RVLS calculated by strain echocardiography correlates with functional capacity and invasive hemodynamic parameters in patients with PAH. The increase of RVLS corresponds with the decrease of mPAP and PVR with specific pulmonary vasodilator therapy. Decrease of mPAP and PVR as a result of treatment was associated with improvement of RVLS.
